NCT01788176View on ClinicalTrials.gov

The Use of Zoledronic Acid to Complex Regional Pain Syndrome

PHASE2UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2016

Conditions
Complex Regional Pain Syndromes
Interventions
DRUG

Zoledronic acid

One single dose of 5mg intravenous infusion of zoledronic acid (interventional group)

DRUG

Placebo

one single intravenous infusion of 100ml of saline.

Trial Locations (1)

05716-150

Centro de Pesquisa Clínica do Instituto de Medicina e Reabilitação do HCFMUSP, São Paulo

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

University of Sao Paulo General Hospital

OTHER